Caenorhabditis elegans for rare disease modeling and drug discovery: strategies and strengths

• Κύριοι συγγραφείς: Peter A. Kropp (Συγγραφέας), Rosemary Bauer (Συγγραφέας), Isabella Zafra (Συγγραφέας), Carina Graham (Συγγραφέας), Andy Golden (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: The Company of Biologists, 2021-08-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Although nearly 10% of Americans suffer from a rare disease, clinical progress in individual rare diseases is severely compromised by lack of attention and research resources compared to common diseases. It is thus imperative to investigate these diseases at their most basic level to build a foundat...